共 17 条
[4]
961 Infliximab Discontinuation in Crohn’s Disease Patients in Stable Remission On Combined Therapy with Immunosuppressors: A Prospective Ongoing Cohort Study[J] . Edouard Louis,Gwenola Vernier-Massouille,Jean-Charles Grimaud,Yoram Bouhnik,David Laharie,Jean-Louis Dupas,Hélène Pillant,Laurence Picon,Michel Veyrac,Mathurin Flamant,Guillaume Savoye,Raymond Jian,Martine De Vos,Gilles Paintaud,Eric Piver,Jean-Frederic Colombel,Jean-Yves Mary,Marc Lemann.Gastroenterology . 2009 (5)
[6]
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial[J] . Geert D’Haens,Filip Baert,Gert van Assche,Philip Caenepeel,Philippe Vergauwe,Hans Tuynman,Martine De Vos,Sander van Deventer,Larry Stitt,Allan Donner,Severine Vermeire,Frank J Van De Mierop,Jean-Charles R Coche,Janneke van der Woude,Thomas Ochsenkühn,Ad A van Bodegraven,Philippe P Van Hootegem,Guy L Lambrecht,Fazia Mana,Paul Rutgeerts,Brian G Feagan,Daniel H
[7]
Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial[J] . Stephen B Hanauer,William J Sandborn,Christian Dallaire,André Archambault,Bruce Yacyshyn,Chyon Yeh,Nancy Smith-Hall.Canadian Journal of Gastroenterology . 2007 (12)
[8]
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine[J] . Marc Lémann,Jean-Yves Mary,Jean-Frédéric Colombel,Bernard Duclos,Jean-Claude Soule,Eric Lerebours,Robert Modigliani,Yoram Bouhnik.Gastroenterology . 2005 (7)
[9]
Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD[J] . Marco Daperno,Geert D’Haens,Gert Van Assche,Filip Baert,Philippe Bulois,Vincent Maunoury,Raffaello Sostegni,Rodolfo Rocca,Angelo Pera,Annemie Gevers,Jean-Yves Mary,Jean-Frédéric Colombel,Paul Rutgeerts.Gastrointestinal Endoscopy . 2004 (4)